Clinical Effects of Rifaximin in Patientswith Hepatic Encephalopathy Intolerant or Nonresponsive to Previous Lactulose Treatment: An Open-Label, Pilot Study
Current Therapeutic Research - United States
doi 10.1016/j.curtheres.2004.10.002
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 2004
Authors
Publisher
Elsevier BV